On September 18, 2025, Bloomberg reported that GE Healthcare is evaluating the possibility of selling a portion of its equity in its China business, with the potential deal valuing the Chinese assets at billions of dollars. Currently, the plan is still in its preliminary stages, and no final decision has been made. In response, GE Healthcare stated that it does not comment on market rumors and emphasized that China is one of the largest medical markets globally, and the company will remain committed to providing high-quality medical services to Chinese patients and customers.